Lewis v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:17-op-45076 |
| Nature of Suit | 370 Torts - Personal Property - Other Fraud |
| Cause | 28:1332 Diversity-Fraud |
| Case Filed: | Dec 15, 2017 |
| Case in other court: | Arkansas Western, 5:17-cv-05118 |
| Last checked: Friday Nov 08, 2019 4:59 PM EST |
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Watson Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
TEVA Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Purdue Frederick Company, Inc.
|
Represented By
|
|
Defendant
Ortho-Mcneil-Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Plaintiff
Michael Ray Lewis
|
Represented By
|
| Docket last updated: 04/08/2019 5:13 PM EDT |
| Thursday, June 29, 2017 | ||
| TEXT ONLY MEMO OF REASSIGNMENT. Case reassigned to Honorable Timothy L. Brooks. Honorable P. K. Holmes, III no longer assigned to the case. (jn) [Transferred from arwd on 12/18/2017.] | ||
| TEXT ONLY CLERK'S NOTICE re Multiple Attorneys Listed on Pleading directed to Plaintiff Michael Ray Lewis. Complaint1 lists multiple attorneys appearing for the filer. The following attorney(s), who did not sign the pleading, must enter a separate Notice of Appearance in order to receive electronic notification of future activity in the case: MARCUS NEIL BOZEMAN, KENNETH R. SHEMIN . (jn) [Transferred from arwd on 12/18/2017.] | ||
| CLERK'S NOTICE REGARDING FILING FEE. The following document was received and filed without the appropriate filing fee:1 Complaint. You MUST pay the filing fee of $ 400.00 or file a motion to proceed In Forma Pauperis, if appropriate, within 2 business days. If the proper fees or motion are not received for case initiating documents, your case may be subject to dismissal. Present your payment to the appropriate Divisional Office or Pay Online, using the Civil -> Other Documents -> Filing Fee Submitted event. Filing Fee due by 7/3/2017 (jn) [Transferred from arwd on 12/18/2017.] | ||
| Remark: Complaint and Docket Sheet sent to Clerk of the Judicial Panel on Multidistrict Litigation via email. (jn) [Transferred from arwd on 12/18/2017.] | ||
| 1 | 1
62
pgs
COMPLAINT with Jury Demand against Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Purdue Pharma L.P., Purdue Pharma, Inc, TEVA Pharmaceuticals USA, Inc., The Purdue Frederick Company, Inc., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc., filed by Michael Ray Lewis.(jn) [Transferred from arwd on 12/18/2017.]
|
|
|
Att: 1
Exh 1,
|
||
|
Att: 2
Exh 2,
|
||
|
Att: 3
Exh 3,
|
||
|
Att: 4
Exh 4,
|
||
|
Att: 5
Exh 5,
|
||
|
Att: 6
Exh 6,
|
||
|
Att: 7
Exh 7,
|
||
|
Att: 8
Exh 8,
|
||
|
Att: 9
Exh 9,
|
||
|
Att: 10
Exh 10,
|
||
|
Att: 11
Exh 11,
|
||
|
Att: 12
Exh 12,
|
||
|
Att: 13
Exh 13,
|
||
|
Att: 14
Exh 14,
|
||
|
Att: 15
Exh 15,
|
||
|
Att: 16
Exh 16,
|
||
|
Att: 17
Exh 17
|
||
| 2 | 2
CIVIL COVER SHEET for case initiated by Michael Ray Lewis. (jn) [Transferred from arwd on 12/18/2017.]
|
|
| 3 | 3
Magistrate Notice/Consent Furnished (jn) [Transferred from arwd on 12/18/2017.]
|
|
| 4 | 4
THE DOCUMENT IS RESTRICTED TO COURT USERS. Summons Issued as to Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Purdue Pharma L.P., Purdue Pharma, Inc, TEVA Pharmaceuticals USA, Inc., The Purdue Frederick Company, Inc., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc. and returned to attorney or plaintiff for service. (jn) [Transferred from arwd on 12/18/2017.]
|
|
| Friday, June 30, 2017 | ||
| Complaint filing fee paid re1 Complaint,, : $ 400, receipt number 0861-1546791.. (Thrash, Thomas) [Transferred from arwd on 12/18/2017.] | ||
| 5 | 5
NOTICE of Appearance by Marcus Neil Bozeman on behalf of Michael Ray Lewis. (Bozeman, Marcus) [Transferred from arwd on 12/18/2017.]
|
|
| Tuesday, August 15, 2017 | ||
| 6 | 6
NOTICE of Appearance by Lyn Peeples Pruitt on behalf of Purdue Pharma L.P., Purdue Pharma, Inc, The Purdue Frederick Company, Inc.. (Pruitt, Lyn) [Transferred from arwd on 12/18/2017.]
|
|
| 7 | 7
MOTION for Extension of Time to File Answer to Complaint by Purdue Pharma L.P., Purdue Pharma, Inc, The Purdue Frederick Company, Inc.. (Pruitt, Lyn) [Transferred from arwd on 12/18/2017.]
|
|
| 8 | 8
**PLEASE DISREGARD, ATTORNEY WILL FILE CORRECT** NOTICE of Appearance by Lyn Peeples Pruitt on behalf of Purdue Pharma L.P., Purdue Pharma, Inc, The Purdue Frederick Company, Inc.. (Pruitt, Lyn) Modified on 8/15/2017 to add text (rg). [Transferred from arwd on 12/18/2017.]
|
|
| 9 | 9
NOTICE of Appearance by Adria Conklin on behalf of Purdue Pharma L.P., Purdue Pharma, Inc, The Purdue Frederick Company, Inc.. (Conklin, Adria) [Transferred from arwd on 12/18/2017.]
|
|
| 10 | 10
NOTICE of Appearance by Sainabou M. Sonko on behalf of Purdue Pharma L.P., Purdue Pharma, Inc, The Purdue Frederick Company, Inc.. (Sonko, Sainabou) [Transferred from arwd on 12/18/2017.]
|
|
| Wednesday, August 16, 2017 | ||
| 11 | 11 TEXT ONLY ORDER granting in part and denying in part7 Separate Defendants' Unopposed Motion for Extension of Time to File Answer or Responsive Pleadings. Separate Defendants' (Purdue Pharma L.P., Purdue Pharma, Inc., and The Purdue Frederick Company, Inc.) responsive pleading must be filed on or before SEPTEMBER 29, 2017. Signed by Honorable Timothy L. Brooks on August 16, 2017. This text-only docket entry is an official and binding order of the court and is intentionally unaccompanied by a separate document. (slc) (A copy of the NEF and document, if attached, will be furnished to any non-ECF Case Participant.) [Transferred from arwd on 12/18/2017.] | |
| Monday, August 21, 2017 | ||
| 12 | 12
Unopposed MOTION for Extension of Time to File Answer Unopposed Motion for Extension of Time for all Defendants to file Answer or Responsive Pleading by Purdue Pharma L.P., Purdue Pharma, Inc, The Purdue Frederick Company, Inc.. (Sonko, Sainabou) [Transferred from arwd on 12/18/2017.]
|
|
| Tuesday, August 22, 2017 | ||
| 13 | 13 TEXT ONLY ORDER GRANTING12 Unopposed Motion for Extension of Time for All Defendants to File Answer or Responsive Pleading. Defendants' responsive pleadings must be filed on or before SEPTEMBER 29, 2017. Signed by Honorable Timothy L. Brooks on August 22, 2017. (slc) [Transferred from arwd on 12/18/2017.] | |
| Tuesday, August 29, 2017 | ||
| 14 | 14
NOTICE of Appearance by James M. Simpson on behalf of Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc.. (Simpson, James) [Transferred from arwd on 12/18/2017.]
|
|
| Thursday, September 21, 2017 | ||
| 15 | 15
NOTICE of Appearance by Brandon B. Cate on behalf of Watson Pharmaceuticals, Inc.. (Cate, Brandon) [Transferred from arwd on 12/18/2017.]
|
|
| 16 | 16
NOTICE of Appearance by Steven W. Quattlebaum on behalf of Watson Pharmaceuticals, Inc.. (Quattlebaum, Steven) [Transferred from arwd on 12/18/2017.]
|
|
| 17 | 17
NOTICE of Appearance by E. B. Chiles, IV on behalf of Watson Pharmaceuticals, Inc.. (Chiles, E.) [Transferred from arwd on 12/18/2017.]
|
|
| Friday, September 29, 2017 | ||
| 18 | 18
NOTICE of Appearance by Lindsey Carroll Pesek on behalf of Watson Pharmaceuticals, Inc.. (Pesek, Lindsey) [Transferred from arwd on 12/18/2017.]
|
|
| 19 | 19
NOTICE of Appearance by Jeff Fletcher on behalf of Endo Health Solutions Inc., Endo Pharmaceuticals, Inc.. (Fletcher, Jeff) [Transferred from arwd on 12/18/2017.]
|
|
| 20 | 20
NOTICE of Appearance by Jess L. Askew, III on behalf of Endo Health Solutions Inc., Endo Pharmaceuticals, Inc.. (Askew, Jess) [Transferred from arwd on 12/18/2017.]
|
|
| 21 | 21
NOTICE of Appearance by Samantha B. Leflar on behalf of Endo Health Solutions Inc., Endo Pharmaceuticals, Inc.. (Leflar, Samantha) [Transferred from arwd on 12/18/2017.]
|
|
| 22 | 22
NOTICE of Appearance by David M. Donovan on behalf of Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., TEVA Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. (Donovan, David) [Transferred from arwd on 12/18/2017.]
|
|
| 23 | 23
MOTION to Dismiss for Failure to State a Claim and to Strike Immaterial and Impertinent Allegations by Endo Health Solutions Inc., Endo Pharmaceuticals, Inc.. (Fletcher, Jeff) [Transferred from arwd on 12/18/2017.]
|
|
| 24 | 24
16
pgs
MEMORANDUM BRIEF in Support of23 MOTION to Dismiss for Failure to State a Claim and to Strike Immaterial and Impertinent Allegations by Endo Health Solutions Inc., Endo Pharmaceuticals, Inc.. (Fletcher, Jeff) [Transferred from arwd on 12/18/2017.]
|
|
| 25 | 25
MOTION to Dismiss for Failure to State a Claim Pursuant to Rules 12(b)(1), 12(b)(2), and 12(b)(6) by Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc.. (Donovan, David) [Transferred from arwd on 12/18/2017.]
|
|
| 26 | 26
20
pgs
MEMORANDUM BRIEF in Support of25 MOTION to Dismiss for Failure to State a Claim Pursuant to Rules 12(b)(1), 12(b)(2), and 12(b)(6) by Actavis LLC, Actavis Pharma, Inc., Watson Laboratories, Inc.. (Donovan, David) [Transferred from arwd on 12/18/2017.]
|
|
| 27 | 27
MOTION to Dismiss for Failure to State a Claim Pursuant to Rules 12(b)(1), 12(b)(2), and 12(b)(6) by Cephalon, Inc., TEVA Pharmaceuticals USA, Inc..(Donovan, David) [Transferred from arwd on 12/18/2017.]
|
|
|
Att: 1
Exhibit ACTIQ Label,
|
||
|
Att: 2
Exhibit Fentora Label,
|
||
|
Att: 3
Exhibit TIRF REMS
|
||
| 28 | 28
28
pgs
MEMORANDUM BRIEF in Support of27 MOTION to Dismiss for Failure to State a Claim Pursuant to Rules 12(b)(1), 12(b)(2), and 12(b)(6) by Cephalon, Inc., TEVA Pharmaceuticals USA, Inc.. (Donovan, David) [Transferred from arwd on 12/18/2017.]
|
|
| 29 | 29
Joint MOTION to Dismiss by Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Purdue Pharma L.P., Purdue Pharma, Inc, TEVA Pharmaceuticals USA, Inc., The Purdue Frederick Company, Inc., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc.. (Pruitt, Lyn) [Transferred from arwd on 12/18/2017.]
|
|
| 30 | 30
30+
pgs
MEMORANDUM BRIEF in Support of29 Joint MOTION to Dismiss by Actavis LLC, Actavis Pharma, Inc., Cephalon, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Purdue Pharma L.P., Purdue Pharma, Inc, TEVA Pharmaceuticals USA, Inc., The Purdue Frederick Company, Inc., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc..(Pruitt, Lyn) [Transferred from arwd on 12/18/2017.]
|
|
|
Att: 1
Exhibit 1,
|
||
|
Att: 2
Exhibit 2,
|
||
|
Att: 3
Exhibit 3,
|
||
|
Att: 4
Exhibit 4,
|
||
|
Att: 5
Exhibit 5,
|
||
|
Att: 6
Exhibit 6,
|
||
|
Att: 7
Exhibit 7,
|
||
|
Att: 8
Exhibit 8,
|
||
|
Att: 9
Exhibit 9,
|
||
|
Att: 10
Exhibit 10,
|
||
|
Att: 11
Exhibit 11,
|
||
|
Att: 12
Exhibit 12
|
||
| 31 | 31
MOTION to Dismiss for Failure to State a Claim and Motion to Strike Improper Allegations by Purdue Pharma L.P., Purdue Pharma, Inc, The Purdue Frederick Company, Inc.. (Pruitt, Lyn) [Transferred from arwd on 12/18/2017.]
|
|
| 32 | 32
MOTION to Dismiss for Failure to State a Claim by Watson Pharmaceuticals, Inc.. (Cate, Brandon) [Transferred from arwd on 12/18/2017.]
|
|
| 33 | 33
12
pgs
MEMORANDUM BRIEF in Support of32 MOTION to Dismiss for Failure to State a Claim by Watson Pharmaceuticals, Inc.. (Cate, Brandon) [Transferred from arwd on 12/18/2017.]
|
|
| 34 | 34
11
pgs
MEMORANDUM BRIEF in Support of31 MOTION to Dismiss for Failure to State a Claim and Motion to Strike Improper Allegations by Purdue Pharma L.P., Purdue Pharma, Inc, The Purdue Frederick Company, Inc.. (Pruitt, Lyn) [Transferred from arwd on 12/18/2017.]
|
|
| 35 | 35
Corporate Disclosure Statement by Purdue Pharma L.P., Purdue Pharma, Inc, The Purdue Frederick Company, Inc.. (Pruitt, Lyn) [Transferred from arwd on 12/18/2017.]
|
|
| 36 | 36
NOTICE of Appearance by Martin A. Kasten on behalf of Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson. (Kasten, Martin) [Transferred from arwd on 12/18/2017.]
|
|
| 37 | 37
MOTION to Dismiss Defendants Johnson & Johnson and Janssen Pharmaceuticals, Inc.'s Motion to Dismiss Plaintiff's Complaint by Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson. (Kasten, Martin) [Transferred from arwd on 12/18/2017.]
|
|
| 38 | 38
20
pgs
MEMORANDUM BRIEF in Support of37 MOTION to Dismiss Defendants Johnson & Johnson and Janssen Pharmaceuticals, Inc.'s Motion to Dismiss Plaintiff's Complaint Defendants Johnson & Johnson and Janssen Pharmaceuticals, Inc.'s Memorandum of Points and Authorities in Support of Motion to Dismiss Plaintiff's Complaint by Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson. (Kasten, Martin) [Transferred from arwd on 12/18/2017.]
|
|
| 39 | 39
MOTION for Attorney Donna M. Welch to Appear Pro Hac Vice . (PHV Application fee paid $ 100; receipt number 0861-1598616) by Watson Pharmaceuticals, Inc.. (Cate, Brandon) [Transferred from arwd on 12/18/2017.]
|
|
| 40 | 40
MOTION for Attorney Jennifer G. Levy to Appear Pro Hac Vice . (PHV Application fee paid $ 100; receipt number 0861-1598619) by Watson Pharmaceuticals, Inc.. (Cate, Brandon) [Transferred from arwd on 12/18/2017.]
|
|
| 41 | 41
MOTION for Attorney Martin L. Roth to Appear Pro Hac Vice . (PHV Application fee paid $ 100; receipt number 0861-1598620) by Watson Pharmaceuticals, Inc.. (Cate, Brandon) [Transferred from arwd on 12/18/2017.]
|
|
| 42 | 42
MOTION for Attorney Timothy W. Knapp to Appear Pro Hac Vice . (PHV Application fee paid $ 100; receipt number 0861-1598621) by Watson Pharmaceuticals, Inc.. (Cate, Brandon) [Transferred from arwd on 12/18/2017.]
|
|
| 43 | 43
Corporate Disclosure Statement by Endo Health Solutions Inc., Endo Pharmaceuticals, Inc.. (Askew, Jess) [Transferred from arwd on 12/18/2017.]
|
|
| Monday, October 02, 2017 | ||
| 44 | 44 TEXT ONLY ORDER GRANTING39 Motion to Appear Pro Hac Vice. Donna M. Welch is directed to immediately register as a CM/ECF user if she has not already done so and enter her appearance in this matter; AND GRANTING40 Motion to Appear Pro Hac Vice. Jennifer G. Levy is directed to immediately register as a CM/ECF user if she has not already done so and enter her appearance in this matter. Signed by Honorable Timothy L. Brooks on October 2, 2017. (slc) [Transferred from arwd on 12/18/2017.] | |
| 45 | 45 TEXT ONLY ORDER GRANTING41 Motion to Appear Pro Hac Vice. Martin L. Roth is directed to immediately register as a CM/ECF user if he has not already done so and enter his appearance in this matter; AND GRANTING42 Motion to Appear Pro Hac Vice. Timothy w. Knapp is directed to immediately register as a CM/ECF user if he has not already done so and enter his appearance in this matter. Signed by Honorable Timothy L. Brooks on October 2, 2017. (slc) [Transferred from arwd on 12/18/2017.] | |
| 46 | 46
MOTION for Attorney Charles C. Lifland to Appear Pro Hac Vice. (PHV Application fee paid $ 100.00; receipt number 2019823) by Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc.. (mjm) [Transferred from arwd on 12/18/2017.]
|
|
| 47 | 47
MOTION for Attorney Jennifer D. Cardelus to Appear Pro Hac Vice. (PHV Application fee paid $ 100.00; receipt number 2019824) by Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc.. (mjm) Modified on 10/2/2017 to correct receipt number (mjm). [Transferred from arwd on 12/18/2017.]
|
|
| 48 | 48
MOTION for Attorney Stephen D. Brody to Appear Pro Hac Vice. (PHV Application fee paid $ 100.00; receipt number 2019822) by Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc.. (mjm) [Transferred from arwd on 12/18/2017.]
|
|
| 49 | 49 TEXT ONLY ORDER GRANTING46 Motion to Appear Pro Hac Vice. Charles C. Lifland is directed to immediately register as a CM/ECF user if he has not already done so and enter his appearance in this matter; AND GRANTING47 Motion to Appear Pro Hac Vice. Jennifer D. Cardelus is directed to immediately register as a CM/ECF user if she has not already done so and enter her appearance in this matter; AND GRANTING48 Motion to Appear Pro Hac Vice. Stephen D. Brody is directed to immediately register as a CM/ECF user if he has not already done so and enter his appearance in this matter. Signed by Honorable Timothy L. Brooks on October 2, 2017. (slc) [Transferred from arwd on 12/18/2017.] | |
| 50 | 50
INITIAL SCHEDULING ORDER: Case Management Hearing set for 11/29/2017 01:30 PM in Fayetteville -- 5th flr (Rm 509) before Honorable Timothy L. Brooks. Rule 26 Meeting Report due by 11/6/2017. Signed by Honorable Timothy L. Brooks on October 2, 2017. (slc) [Transferred from arwd on 12/18/2017.]
|
|
| Thursday, October 05, 2017 | ||
| 51 | 51
NOTICE of Appearance by Donna Marie Welch on behalf of Watson Pharmaceuticals, Inc.. (Welch, Donna) [Transferred from arwd on 12/18/2017.]
|
|
| 52 | 52
NOTICE of Appearance by Martin Louis Roth on behalf of Watson Pharmaceuticals, Inc.. (Roth, Martin) [Transferred from arwd on 12/18/2017.]
|
|
| 53 | 53
NOTICE of Appearance by Timothy William Knapp on behalf of Watson Pharmaceuticals, Inc.. (Knapp, Timothy) [Transferred from arwd on 12/18/2017.]
|
|
| 54 | 54
NOTICE of Appearance by Jennifer Gardner Levy on behalf of Watson Pharmaceuticals, Inc.. (Levy, Jennifer) [Transferred from arwd on 12/18/2017.]
|
|
| Wednesday, October 11, 2017 | ||
| 55 | 55
Joint MOTION for Extension of Time to File Response/Reply to Defendants' Motions to Dimiss , Joint MOTION for Leave to File Reply by Michael Ray Lewis. (Bozeman, Marcus) [Transferred from arwd on 12/18/2017.]
|
|
| 56 | 56 TEXT ONLY ORDER granting in part and denying in part55 Motion for Extension of Time to File Response/Reply and granting55 Motion for Leave to File. Plaintiffs' Responses in Opposition to the Motions to Dismiss will be due on or before October 27, 2017. Defendants are granted leave to file Replies in support of the Motions to Dismiss. Those Replies will be due on or before November 10, 2017. Signed by Honorable Timothy L. Brooks on October 11, 2017. (kce) [Transferred from arwd on 12/18/2017.] | |
| Wednesday, October 25, 2017 | ||
| 57 | 57
ORDER holding present case in abeyance for a period not to exceed 90 days pending further rulings from the JPMDL. See order for specifics. Signed by Honorable Timothy L. Brooks on October 25, 2017. (src) [Transferred from arwd on 12/18/2017.]
|
|
| Thursday, October 26, 2017 | ||
| ***CASE MANAGEMENT HEARING and all related deadlines terminated. See Order57 . Signed by Honorable Timothy L. Brooks on October 26, 2017. (slc) [Transferred from arwd on 12/18/2017.] | ||
| Friday, December 01, 2017 | ||
| 58 | 58
STATUS REPORT by Purdue Pharma L.P., Purdue Pharma, Inc, The Purdue Frederick Company, Inc.. (Pruitt, Lyn) [Transferred from arwd on 12/18/2017.]
|
|
| 59 | 59
Corporate Disclosure Statement by Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc.. (Lifland, Charles) [Transferred from arwd on 12/18/2017.]
|
|
| 60 | 60
STATUS REPORT by Michael Ray Lewis. (Bozeman, Marcus) [Transferred from arwd on 12/18/2017.]
|
|
| Thursday, December 14, 2017 | ||
| 61 | 61
MDL CONDITIONAL TRANSFER ORDER. Case transferred to District of Northern District of Ohio. Documents transmitted as requested. (src) [Transferred from arwd on 12/18/2017.]
|
|